$74.74
0.32%
Downside
Day's Volatility :1.36%
Upside
1.04%
11.23%
Downside
52 Weeks Volatility :26.33%
Upside
17.01%
Period | Dolby Laboratories, Inc. | Sector (Technology) | Index (Russel 2000) |
---|---|---|---|
3 Months | -4.82% | -3.3% | 0.0% |
6 Months | -8.97% | 9.1% | 0.0% |
1 Year | -6.39% | 33.9% | 0.0% |
3 Years | -15.65% | 47.7% | -21.4% |
Market Capitalization | 7.2B |
Book Value | $25.45 |
Dividend Share | 1.2 |
Dividend Yield | 1.58% |
Earnings Per Share (EPS) | 2.18 |
PE Ratio | 34.73 |
PEG Ratio | 2.08 |
Wall Street Target Price | 99.0 |
Profit Margin | 16.87% |
Operating Margin TTM | 14.15% |
Return On Assets TTM | 5.16% |
Return On Equity TTM | 8.92% |
Revenue TTM | 1.3B |
Revenue Per Share TTM | 13.17 |
Quarterly Revenue Growth YOY | -3.2% |
Gross Profit TTM | 1.1B |
EBITDA | 322.1M |
Diluted Eps TTM | 2.18 |
Quarterly Earnings Growth YOY | 1.35 |
EPS Estimate Current Year | 3.7 |
EPS Estimate Next Year | 3.81 |
EPS Estimate Current Quarter | 0.59 |
EPS Estimate Next Quarter | 0.85 |
What analysts predicted
Upside of 32.46%
FY18 | Y/Y Change | |
---|---|---|
Revenue | 1.2B | ↑ 8.37% |
Net Income | 122.2M | ↓ 39.42% |
Net Profit Margin | 10.43% | ↓ 8.23% |
FY19 | Y/Y Change | |
---|---|---|
Revenue | 1.2B | ↑ 5.95% |
Net Income | 255.2M | ↑ 108.72% |
Net Profit Margin | 20.55% | ↑ 10.12% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 1.2B | ↓ 6.43% |
Net Income | 231.4M | ↓ 9.32% |
Net Profit Margin | 19.91% | ↓ 0.64% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 1.3B | ↑ 10.28% |
Net Income | 310.2M | ↑ 34.09% |
Net Profit Margin | 24.21% | ↑ 4.3% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 1.3B | ↓ 2.14% |
Net Income | 184.1M | ↓ 40.66% |
Net Profit Margin | 14.68% | ↓ 9.53% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 1.0B | ↓ 19.51% |
Net Income | 191.5M | ↑ 4.01% |
Net Profit Margin | 18.97% | ↑ 4.29% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Revenue | 375.9M | ↑ 12.23% |
Net Income | 95.7M | ↑ 20.56% |
Net Profit Margin | 25.46% | ↑ 1.76% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 298.4M | ↓ 20.62% |
Net Income | 16.4M | ↓ 82.86% |
Net Profit Margin | 5.5% | ↓ 19.96% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 290.6M | ↓ 2.62% |
Net Income | 9.2M | ↓ 43.98% |
Net Profit Margin | 3.16% | ↓ 2.34% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 315.6M | ↑ 8.61% |
Net Income | 67.0M | ↑ 629.16% |
Net Profit Margin | 21.23% | ↑ 18.07% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Revenue | 364.5M | ↑ 15.51% |
Net Income | 97.8M | ↑ 46.06% |
Net Profit Margin | 26.84% | ↑ 5.61% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Revenue | 288.8M | ↓ 20.77% |
Net Income | 38.4M | ↓ 60.7% |
Net Profit Margin | 13.31% | ↓ 13.53% |
FY18 | Y/Y Change | |
---|---|---|
Total Assets | 2.7B | ↑ 4.96% |
Total Liabilities | 463.2M | ↑ 18.84% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 2.8B | ↑ 6.11% |
Total Liabilities | 508.7M | ↑ 9.84% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 2.9B | ↑ 3.39% |
Total Liabilities | 478.9M | ↓ 5.86% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 3.1B | ↑ 6.46% |
Total Liabilities | 501.5M | ↑ 4.71% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 2.7B | ↓ 13.4% |
Total Liabilities | 438.5M | ↓ 12.55% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 3.0B | ↑ 10.79% |
Total Liabilities | 607.6M | ↑ 38.55% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 2.8B | ↑ 3.19% |
Total Liabilities | 480.1M | ↑ 5.29% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 3.0B | ↑ 6.06% |
Total Liabilities | 625.2M | ↑ 30.21% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 3.0B | ↓ 0.94% |
Total Liabilities | 607.6M | ↓ 2.82% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 2.9B | ↓ 1.48% |
Total Liabilities | 573.2M | ↓ 5.66% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 3.0B | ↑ 3.72% |
Total Liabilities | 607.0M | ↑ 5.9% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 3.0B | ↓ 2.33% |
Total Liabilities | 526.2M | ↓ 13.32% |
FY18 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 352.2M | ↓ 5.08% |
Investing Cash Flow | 78.1M | ↓ 148.28% |
Financing Cash Flow | -133.6M | ↑ 33.51% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 327.7M | ↓ 6.96% |
Investing Cash Flow | -56.2M | ↓ 172.01% |
Financing Cash Flow | -385.3M | ↑ 188.32% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 343.8M | ↑ 4.94% |
Investing Cash Flow | 134.4M | ↓ 338.98% |
Financing Cash Flow | -207.8M | ↓ 46.07% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 447.8M | ↑ 30.22% |
Investing Cash Flow | -44.9M | ↓ 133.42% |
Financing Cash Flow | -252.5M | ↑ 21.53% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 318.6M | ↓ 28.85% |
Investing Cash Flow | -295.9M | ↑ 559.02% |
Financing Cash Flow | -610.6M | ↑ 141.79% |
FY23 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 282.1M | ↓ 11.46% |
Investing Cash Flow | 54.2M | ↓ 118.32% |
Financing Cash Flow | -194.0M | ↓ 68.22% |
Q1 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 104.5M | ↑ 85.37% |
Investing Cash Flow | 23.6M | ↓ 16.66% |
Financing Cash Flow | -67.1M | ↓ 25.53% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 121.1M | ↑ 15.87% |
Investing Cash Flow | 22.0M | ↓ 6.59% |
Financing Cash Flow | -36.8M | ↓ 45.12% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 85.0M | ↓ 29.81% |
Investing Cash Flow | -19.7M | ↓ 189.47% |
Financing Cash Flow | -42.8M | ↑ 16.22% |
Sell
Neutral
Buy
Dolby Laboratories, Inc. is currently in a neutral trading position according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Dolby Laboratories, Inc. | 9.55% | -8.97% | -6.39% | -15.65% | 19.97% |
Copart, Inc. | 7.04% | -6.01% | 17.01% | 50.2% | 165.3% |
Thomson Reuters Corp. | -1.59% | 7.76% | 31.05% | 46.0% | 147.2% |
Global Payments Inc. | -10.32% | -22.97% | -13.31% | -38.29% | -38.42% |
Rb Global Inc | -2.72% | 8.86% | 22.1% | 26.4% | 106.22% |
Cintas Corporation | 1.85% | 20.99% | 63.2% | 104.5% | 214.07% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Dolby Laboratories, Inc. | 34.73 | 34.73 | 2.08 | 3.7 | 0.09 | 0.05 | 0.02 | 25.45 |
Copart, Inc. | 37.79 | 37.79 | 2.92 | 1.44 | 0.2 | 0.13 | NA | 7.81 |
Thomson Reuters Corp. | 32.28 | 32.28 | 3.64 | 3.76 | 0.2 | 0.06 | 0.01 | 25.83 |
Global Payments Inc. | 18.1 | 18.1 | 0.38 | 11.59 | 0.06 | 0.03 | 0.01 | 88.02 |
Rb Global Inc | 44.62 | 44.62 | 0.71 | 4.51 | 0.07 | 0.04 | 0.01 | 27.98 |
Cintas Corporation | 51.88 | 51.88 | 4.46 | 14.95 | 0.4 | 0.15 | 0.01 | 9.97 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Dolby Laboratories, Inc. | Buy | $7.2B | 19.97% | 34.73 | 16.87% |
Copart, Inc. | Buy | $51.0B | 165.3% | 37.79 | 32.17% |
Thomson Reuters Corp. | Hold | $74.8B | 147.2% | 32.28 | 33.65% |
Global Payments Inc. | Buy | $25.1B | -38.42% | 18.1 | 14.26% |
Rb Global Inc | Buy | $15.0B | 106.22% | 44.62 | 8.68% |
Cintas Corporation | Buy | $82.6B | 214.07% | 51.88 | 16.8% |
Insights on Dolby Laboratories, Inc.
Revenue is down for the last 2 quarters, 364.52M → 288.81M (in $), with an average decrease of 20.8% per quarter
Netprofit is down for the last 2 quarters, 97.83M → 38.44M (in $), with an average decrease of 60.7% per quarter
In the last 1 year, Cintas Corporation has given 66.2% return, outperforming this stock by 72.3%
In the last 3 years, Cintas Corporation has given 104.5% return, outperforming this stock by 120.2%
Vanguard Group Inc
Morgan Stanley - Brokerage Accounts
BlackRock Inc
Kayne Anderson Rudnick Investment Management LLC
Ninety One UK Limited
Bank of New York Mellon Corp
In the quarter ending March,2024. Dolby Laboratories, Inc. has declared dividend of $0.3
Read Morewe're the rain on the roof in a movie. the music flowing through your earbuds when you're at the gym. the footsteps lurking behind you in a video game. the voice of a colleague on a call who seems to be right next to you. the sight of a breathtakingly bright and vivid sunset on your tv. making experiences come alive through technology is what we do. it's been our mission since day one. it began with our founder, ray dolby, a visionary scientist and inventor. as a young engineer and music lover, he was driven to improve the listening experience. and with that simple motivation, plus countless hours of experimentation, he created a solution—a solution that was elegant and practical, highly sophisticated, and wholly devoted to the artist's vision. even as we've become a global company, dolby laboratories continues to reflect ray dolby's values. here, science meets art. and high tech goes far beyond computer code. founded in 1965 and headquartered in san francisco, dolby has grown into a l
Organization | Dolby Laboratories, Inc. |
Employees | 2246 |
CEO | Mr. Kevin J. Yeaman |
Industry | Manufacturing |